US2009087466A1PendingUtilityA1
Process for providing antimicrobial surfaces
Est. expiryOct 3, 2025(expired)· nominal 20-yr term from priority
A61L 31/047A61L 29/08A61K 38/16A61L 29/16A61K 38/10A61L 2300/606A61L 29/048A61L 2300/25A61L 31/16A61L 2300/404C09D 5/14A61L 31/08
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Processes for providing durable antimicrobial surfaces are disclosed that comprise treating a polymer substrate surface with formaldehyde followed by treatment with an antimicrobial peptide. Further embodiments include articles, including medical devices, characterized by a durable antimicrobial surface provided by the processes of the invention.
Claims
exact text as granted — not AI-modified1 . A process for providing a durable antimicrobial surface on a polymer substrate comprising:
a) treating a polymer substrate with a first fluid comprising formaldehyde and a co-reactant selected from the group: acid, anhydride, reactive halide, or mixtures thereof; wherein the formaldehyde and co-reactant are present in amounts effective to provide a polymer substrate with a chemically modified surface; and b) treating the chemically modified surface of step (a) with an antimicrobial fluid comprising an effective amount of an antimicrobial peptide sufficient to provide a durable antimicrobial surface.
2 . A process for providing a durable antimicrobial surface on a polymer substrate comprising:
a) (1) treating a polymer substrate with a first alternative fluid comprising formaldehyde and a hydroxymethylation catalyst wherein the formaldehyde and hydroxymethylation catalyst are present in an amount effective to provide a polymer substrate with a hydroxymethyl surface;
(2) treating the hydroxymethyl surface with a second alternative fluid comprising a reactant selected from the group: acid, anhydride, reactive halide, and mixtures thereof, in an amount effective to provide a polymer substrate with a chemically modified surface; and
b) treating the chemically modified surface of step (a) (2), with an antimicrobial fluid comprising an effective amount of an antimicrobial peptide sufficient to provide a durable antimicrobial surface.
3 . The process of claims 1 or 2 , wherein the antimicrobial fluid further comprises an effective amount of base catalyst.
4 . The process of claims 1 or 2 wherein the antimicrobial fluid further comprises a base catalyst selected from the group: potassium hydroxide, sodium hydroxide, potassium carbonate, sodium carbonate, trimethylamine, triethylamine, tripropylamine, diisopropylethylamine and tributyl amine.
5 . The process of claims 1 or 2 , wherein the polymer substrate of step (a) is comprised of one or more homopolymers, copolymers, block copolymers or graft polymers selected from the group: polyamide, polyurethane, and polyurea.
6 . The process of claims 1 or 2 , wherein the polymer substrate of step (a) is a thermoplastic polyurethane elastomer.
7 . The process of claims 1 or 2 , wherein said antimicrobial peptide is characterized by a weight average molecular weight of about 1000 to about 60,000 Daltons.
8 . The process of claims 1 or 2 , wherein said antimicrobial peptide is one or more linear cationic peptide(s).
9 . The process of claims 1 or 2 , wherein the durable antimicrobial surface is provided on a medical device.
10 . The process of claims 1 or 2 , wherein said formaldehyde is selected from the group: aqueous formaldehyde, paraformaldehyde and trioxane.
11 . The process of claim 1 wherein the co-reactant of step (a) is selected from the group: trimethylsilylchloride, trimethylsilylbromide, and hydrogen chloride.
12 . The process of claim 2 wherein the reactant of step (a) (2) is selected from the group: trimethylsilylchloride, trimethylsilylbromide, and hydrogen chloride.
13 . The process of claim 1 , wherein said first fluid consists essentially of paraformaldehyde and trimethylsilylchloride.
14 . The process of claims 1 or 2 , wherein treating the chemically modified surface with said antimicrobial fluid is performed at a reaction temperature of about 4° C. to about 100° C., for a reaction time of about 0.1 to about 10 hours.
15 . The process of claim 2 , wherein said hydroxymethylation catalyst is selected from the group: hydrogen chloride, sulfuric acid, glacial acetic acid formic acid, sodium hydroxide, potassium hydroxide, sodium carbonate and potassium carbonate.
16 . The process of claims 1 or 2 , wherein the antimicrobial peptide is characterized by a weight average molecular weight of about 1,000 to about 60,000 Daltons and contains a net positive charge of greater than 1 at physiological pH.
17 . The process of claims 1 or 2 , wherein the antimicrobial peptide is selected from the group consisting of linear cationic α-helical peptides of 8 to 40 amino acid residues.
18 . The process of claims 1 or 2 , wherein the antimicrobial peptide is selected from the group:
(SEQ ID NO: 1)
PKGLKKLLKGLKKLLKL
(SEQ ID NO: 2)
KGLKKLLKGLKKLLKL
(SEQ ID NO: 3)
KGLKKLLKLLKKLLKL
(SEQ ID NO: 4)
LKKLLKLLKKLLKL
(SEQ ID NO: 5)
LKKLLKLLKKLL
(SEQ ID NO: 6)
VAKKLAKLAKKLAKLAL
(SEQ ID NO: 7)
FAKLLAKALKKLL
(SEQ ID NO: 8)
KGLKKGLKLLKKLLKL
(SEQ ID NO: 9)
KGLKKLLKLGKKLLKL
(SEQ ID NO: 10)
KGLKKLGKLLKKLLKL
(SEQ ID NO: 11)
KGLKKLLKLLKKGLKL
(SEQ ID NO: 12)
KGLKKLLKLLKKLGKL
(SEQ ID NO: 13)
FALALKALKKLKKALKKAL
(SEQ ID NO: 14)
FAKKLAKLAKKLAKLAL
(SEQ ID NO: 15)
FAKLLAKLAKKLL
(SEQ ID NO: 16)
FAKKLAKLALKLAKL
(SEQ ID NO: 17)
FAKKLAKKLL
(SEQ ID NO: 18)
FAKLLAKLAKKVL
(SEQ ID NO: 19)
KYKKALKKLAKLL
(SEQ ID NO: 20)
FALLKALLKKAL
(SEQ ID NO: 21)
KRLFKKLKFSLRKY
(SEQ ID NO: 22)
KRLFKKLLFSLRKY
(SEQ ID NO: 23)
LLLFLLKKRKKRKY
(SEQ ID NO: 24)
KWKLFKKIEKVGQNIRDGIIKAGPAVAWGQATQIAK
(SEQ ID NO: 25)
GIGKFLHSAKKFGKAFVGEIMNS
(SEQ ID NO: 26)
GIGKFLKKAKKFGKAFVKILKK
(SEQ ID NO: 27)
RLCRIVVIRVCR
(SEQ ID NO: 28)
ILPWKWPWWPWRR
(SEQ ID NO: 29)
DSHAKRHHGYKRKFHEKHHSHRGY.
19 . The process of claims 1 or 2 , wherein the polymer substrate is a nonwoven fabric.
20 . The process of claims 1 or 2 , wherein the polymer substrate is a fiber.
21 . The process of claims 1 or 2 , wherein the polymer substrate is a film.
22 . The process of claim 1 or 2 , wherein the polymer substrate is selected from the group: catheters, pacemaker leads, vascular grafts, blood tubing, balloons, shunts, cardiac-assist devices, and urological implants; and barrier materials selected from the group: wound dressings, surgical gowns, gloves, aprons, and drapes.
23 . An article selected from the group consisting of a non-woven fabric, fiber, film, catheters, pacemaker leads, vascular grafts, blood tubing, balloons, shunts, cardiac-assist devices, and urological implants; and barrier materials selected from the group: wound dressings, surgical gowns, gloves, aprons, and drapes, characterized by a durable antimicrobial surface provided by the process of claims 1 or 2 .
24 . A medical device characterized by a durable antimicrobial polymeric surface provided by the process of claims 1 or 2 .
25 . The process of claims 1 or 2 , further comprising washing said durable antimicrobial surface with one or more wash solvents to remove excess antimicrobial peptide, base if used, and any byproducts; to provide a durable antimicrobial surface substantially free of non-bonded contaminants.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.